Surgery Partners Q4 Profit Plummets 73%, Missing Estimates

Edgen Stock·Mar 03 2026, 00:01

Share to

Share to

Copy link

Key Takeaways

Surgery Partners (SGRY) reported fourth-quarter financial results that fell significantly short of both analyst expectations and its prior-year performance. The steep drop in profitability raises questions about the company's operational standing and is poised to negatively affect its stock valuation.

Quarterly earnings per share came in at $0.12, missing the Zacks Consensus Estimate of $0.31 by over 61%.
The result marks a 73% decline in earnings from the $0.44 per share reported in the same quarter a year ago.
The substantial earnings miss is likely to trigger analyst downgrades and a negative investor reaction, impacting SGRY's stock price.

Q4 Earnings Fall 61% Short of Analyst Expectations

Surgery Partners (SGRY) announced fourth-quarter earnings of just $0.12 per share, a figure that significantly underperformed market forecasts. The result missed the Zacks Consensus Estimate of $0.31 per share by a wide margin, signaling unexpected challenges for the ambulatory surgery center operator.

Profits Decline 73% From Prior-Year Period

The company's performance represents a sharp deterioration from the previous year. The reported earnings of $0.12 per share is a 73% collapse from the $0.44 per share earned in the same quarter one year ago. This steep year-over-year decline suggests mounting operational or financial pressures. Investors are likely to re-evaluate the company's future earnings potential, which could lead to a significant sell-off in its stock and prompt analysts to revise their ratings downward.